Want to see SE:ELIC full AI Analyst Report?
Elicera Therapeutics AB (ELIC) Income Statement
Elicera Therapeutics AB Income Statement
Last quarter (Q2 2026), Elicera Therapeutics AB's total revenue was $-147.66K, a decrease of 105.48% from the same quarter last year. In Q2, Elicera Therapeutics AB's net income was $-6.26M. See Elicera Therapeutics AB’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 7.13M | $ 11.23M | $ 1.28M | $ 587.00 | |
| $ 0.00 | $ 7.13M | $ 11.22M | $ 1.28M | $ -11.19K | |
| $ 17.94M | $ 24.01M | $ 28.33M | $ 20.64M | $ 13.12M | |
| Depreciation and Amortization | $ 0.00 | $ 11.78K | $ 11.77K | $ 11.79K | $ 11.78K |
| $ -17.40M | $ -16.87M | $ -17.08M | $ -19.43M | $ -13.11M | |
| $ -17.94M | $ -16.88M | $ -28.33M | $ -19.36M | $ -13.12M | |
| $ 538.02K | $ 773.73K | $ 11.93M | $ -75.88K | $ -1.07K | |
| $ -17.41M | $ -16.11M | $ -16.40M | $ -19.44M | $ -13.12M | |
| $ -17.41M | $ -16.11M | $ -16.40M | $ -19.52M | $ -13.12M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.38 | $ -0.51 | $ -0.83 | $ -0.98 | $ -0.82 |
| Diluted EPS | $ -0.37 | $ -0.51 | $ -0.83 | $ -0.98 | $ -0.82 |
| Weighted Average Shares Outstanding | 45.58M | 31.57M | 19.78M | 19.78M | 15.94M |
| Weighted Average Shares Outstanding (Diluted) | 48.19M | 31.57M | 19.78M | 19.78M | 15.94M |
Currency in SEK